Tissue engineering of the aortic heart valve : fundamentals and developments / Yosry S. Morsi.

Saved in:
Bibliographic Details
Main Author: Morsi, Yosry S. (Author)
Format: eBook
Language:English
Published: [Hauppauge] New York : Nova Science Publishers, Inc., [2012]
Series:Cardiology research and clinical developments series.
Subjects:
Online Access:Click for online access
Table of Contents:
  • TISSUE ENGINEERING OF THE AORTIC HEART VALVE ; Library of Congress Cataloging-in-Publication Data ; Contents ; Preface ; Chapter I Why Tissue Engineering of Heart Valve ; 1.1. Overview ; 1.2. The Book Structure; References ; Chapter II Basic Introduction to Heart Valve Diseases ; 2.1. An Overview ; 2.2. Anatomy of the Heart and Valves ; 2.2.1. Human Heart ; 2.2.2. Function, Anatomy and Locations of Heart Valves ; 2.2.3. Atrioventricular Valves (AV Valves) ; A. Tricuspid Valve ; B. Mitral Valve ; 2.2.4. Semilunar Valves (SV) ; A. Aortic Valve ; B. Pulmonary Valve.
  • 2.2.5. Tissue Structure, Extra Cellular Matrix (ECM) of Aortic Valve 2.3. The Cardiac Cycle ; 2.4. Valvular Heart Disease (VHD) ; 2.4.1. Overview ; 2.4.2. Infective Endocarditis (Bacterial Endocarditis) ; 2.4.3. Myxomatus Degeneration ; 2.4.4. Calcific Degeneration ; 2.4.5. Congenital Anomalies ; 2.5. Diseases of Aortic Valve ; 2.5.1. Overview ; 2.5.2. Aortic Regurgitation (AR) ; 2.5.3. Aortic Stenosis (AS) ; 2.5.4. Bicuspid Aortic Valve ; 2.6. Valvular Heart Disease and Diagnostic Techniques ; References ; Chapter III Heart Valve Replacements ; 3.1. Overview.
  • 3.2. Type of Valve Replacements 3.2.1. Mechanical Valves ; 3.2.1.1. Mechanical Caged-Ball ; 3.2.1.2. Tilting-Disk Valve ; 3.2.2. Tissue Bio-Prosthetic Valves ; 3.2.2.1. Homografts or Allograft Valves ; 3.2.2.2. Autografts and Ross Procedure ; 3.2.3. Xenografts or Hetrografts ; 3.3. Complications and Limitations of Artificial Heart Valves: An Overview ; References ; Chapter IV Biomaterials Characterisation ; 4.1. Introduction ; 4.2. Biological Materials ; 4.2.1. Collagen ; 4.2.2. Gelatin ; 4.2.3. Alginate ; 4.2.4. Hyaluronic Acid (HA) ; 4.2.5. Chitin and Chitosan.
  • 4.2.6. Compound of Biological Materials 4.3. Synthetic Polymeric Materials ; 4.3.1. Overview ; 4.3.2. Major Classes of Degradable Polymers ; 4.3.2.1. Poly (Ü-esters) ; 4.3.2.2. Poly (Glycolic Acid), Poly(Lactic Acid) and Their Copolymers ; 4.3.2.3. Poly(Caprolactone) ; 4.3.2.4. Poly(Propylene Fumarates) ; 4.3.2.5. Polyanhydrides ; 4.3.2.6. Polyurethane ; 4.3.2.7. Poly (Ether Ester Amide) ; 4.3.2.8. Poly (Ortho Esters) ; 4.3.2.9. Pseudo Poly (Amino Acid) ; 4.3.2.10. Poly (Alkyl Cyanoacrylates) ; 4.3.2.11. Polyphosphazenes ; 4.3.2.12. Polyphosphoester ; 4.3.2.13. Hydrogel Materials.
  • 4.3.3. Properties of Materials for Soft Tissue Engineering 4.4. Final Remarks ; References ; Chapter V Scaffold Fabrication Techniques ; 5.1. Introduction ; 5.2. Scaffold Fabrication Methods ; 5.2.1. Conventional Techniques ; 5.2.2. Gas Foaming ; 5.2.3. Fibre Bonding ; 5.2.4. Phase Separation ; 5.2.5. Particulate Leaching ; 5.3. Textile Technique for Manufacturing Scaffold ; 5.3.1. The Principle of Membranes Lamination ; 5.4 Rapid Prototyping ; 5.4.1. Selective Laser Sintering (SLS) ; 5.4.2. 3D Ink-jet Printing ; 5.4.3. Fused Deposition Modelling (FDM) ; 5.4.4. Stereolithography (SLA).